Documentation Centre

 

 

  of 709 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Novel protein glycan-derived markers of systemic inflammation and C-reactive protein in relation to glycemia, insulin resistance, and insulin secretion. Diabetes Care. 2017;40:375-382 August 10, 2017 Novel protein glycan-derived markers of systemic inflammation and C-reactive protein in relation to glycemia, insulin resistance, and insulin secretion. Diabetes Care. 2017;40:375-382 Lorenzo C, Festa A, Hanley AJ, Rewers MJ, Escalante A, Haffner SM Key Publications
Serum levels of apolipoproteins and incident type 2 diabetes: A prospective cohort study. Diabetes Care. 2017;40:346-351 August 10, 2017 Serum levels of apolipoproteins and incident type 2 diabetes: A prospective cohort study. Diabetes Care. 2017;40:346-351 Brahimaj A, Ligthart S, Ikram MA, Hofman A, Franco OH, Sijbrands EJ, Kavousi M, Dehghan A Key Publications
Identification of dietary patterns associated with obesity in a nationally representative survey of Canadian adults: application of a priori, hybrid, and simplified dietary pattern techniques. Am J Clin Nutr. 2017;105:669-684 August 04, 2017 Identification of dietary patterns associated with obesity in a nationally representative survey of Canadian adults: application of a priori, hybrid, and simplified dietary pattern techniques. Am J Clin Nutr. 2017;105:669-684 Vanegas SM, Meydani M, Barnett JB, Goldin B, Kane A, Rasmussen H, Brown C, Vangay P, Knights D, Jonnalagadda S, Koecher K, Karl JP, Thomas M, Dolnikowski G, Li L, Saltzman E, Wu D, Meydani SN Key Publications
Exercise-stimulated glucose uptake - regulation and implications for glycaemic control. Nat Rev Endocrinol. 2017;13:133-148 July 31, 2017 Exercise-stimulated glucose uptake - regulation and implications for glycaemic control. Nat Rev Endocrinol. 2017;13:133-148 Sylow L, Kleinert M, Richter EA, Jensen TE Key Publications
C-reactive protein levels are inversely correlated with the apolipoprotein B-48-containing triglyceride-rich lipoprotein production rate in insulin resistant men. Metabolism. 2017;68:163-172 July 27, 2017 C-reactive protein levels are inversely correlated with the apolipoprotein B-48-containing triglyceride-rich lipoprotein production rate in insulin resistant men. Metabolism. 2017;68:163-172 Drouin-Chartier JP, Tremblay AJ, Hogue JC, Leclerc M, Labonté MÈ, Marin J, Lamarche B, Couture P Key Publications
Consumption of red and processed meat and refined grains for 4weeks decreases insulin sensitivity in insulin-resistant adults: A randomized crossover study. Metabolism. 2017;68:173-183 July 27, 2017 Consumption of red and processed meat and refined grains for 4weeks decreases insulin sensitivity in insulin-resistant adults: A randomized crossover study. Metabolism. 2017;68:173-183 Kim Y, Keogh JB, Clifton PM Key Publications
Similar metabolic response to lower- versus upper-body interval exercise or endurance exercise. Metabolism. 2017;68:1-10 July 27, 2017 Similar metabolic response to lower- versus upper-body interval exercise or endurance exercise. Metabolism. 2017;68:1-10 Francois ME, Graham MJ, Parr EB, Rehrer NJ, Lucas SJ, Stavrianeas S, Cotter JD Key Publications
Vitamin D status, gender differences, and cardiometabolic health disparities. Ann Nutr Metab. 2017;70:79-87 July 21, 2017 Vitamin D status, gender differences, and cardiometabolic health disparities. Ann Nutr Metab. 2017;70:79-87 Sanghera DK, Sapkota BR, Aston CE, Blackett PR Key Publications
Effects and prevalence of nonresponders after 12 weeks of high-intensity interval or resistance training in women with insulin resistance: a randomized trial. J Appl Physiol (1985). 2017;122:985-996 July 18, 2017 Effects and prevalence of nonresponders after 12 weeks of high-intensity interval or resistance training in women with insulin resistance: a randomized trial. J Appl Physiol (1985). 2017;122:985-996 Álvarez C, Ramírez-Campillo R, Ramírez-Vélez R, Izquierdo M Key Publications
Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial. Am Heart J. 2017;186:73-82 July 14, 2017 Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial. Am Heart J. 2017;186:73-82 Sharma A, de Souza Brito F, Sun JL, Thomas L, Haffner S, Holman RR, Lopes RD Key Publications

  of 709 Next page

Go to page: of